Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial

Richard G. Langley, Steven R. Feldman, Chenglong Han, Brad Schenkel, Philippe Szapary, Ming Chun Hsu, Jean Paul Ortonne, Kenneth B. Gordon, Alexa B. Kimball

Research output: Contribution to journalArticlepeer-review

153 Scopus citations

Fingerprint

Dive into the research topics of 'Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial'. Together they form a unique fingerprint.

Medicine & Life Sciences